†with Suda as the first affiliation; #co-first authors; *corresponding author

1.    †Bao X, Zhu Q, Xue S, Xu Y, Ma X, Chen F, Hu X, Zhu Z, Chen S, Sun A, Wu D, Song Y, Qiu H*. Risk factors of clinically refractory CMV reactivation following allogeneic HSCT: a single-center study in China. Bone Marrow Transplant 2016;51:1625-7.

2.    †Cao Y, Fang Y, Cai J, Li X, Xu F, Yuan N, Zhang S, Wang J*. ROS functions as an upstream trigger for autophagy to drive hematopoietic stem cell differentiation. Hematology 2016;21:613-8.

3.    †Cao Y#*, Cai J#, Li X#, Yuan N, Zhang S*. Autophagy governs erythroid differentiation both in vitro and in vivo. Hematology 2016;21:225-33.

4.    †Chen D#, Zou J#, Zong Y, Meng H, An G, Yang L*. Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization. Immunopharmacol Immunotoxicol 2016;38:175-83.

5.    Chen L, Li J, Wang F, Dai C, Wu F, Liu X, Li T, Glauben R, Zhang Y, Nie G, He Y*, Qin Z*. Tie2 expression on macrophages is required for blood vessel reconstruction and tumor relapse after chemotherapy. Cancer Res 2016;76:6828-38.

6.    Chen QY#*, Jiao DM#, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J*, Wang Z*. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/ Akt/mTOR pathway. Oncotarget 2016;7:18247-61.

7.    †Chen T#, Xu D#, Li Q, Mou P, Zeng Z, Brass LF, Zhu L*. The regulation of Sema4D exodomain shedding by protein kinase A in platelets. Platelets 2016;27:673-9.

8.    †Chu M#, Li T#, Shen B, Cao X, Zhong H, Zhang L, Zhou F, Ma W, Jiang H, Xie P, Liu Z, Dong N, Xu Y, Zhao Y, Xu G, Lu P, Luo J, Wu Q, Alitalo K, Koh GY, Adams RH, He Y*. Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII. ELife 2016 Dec 22;5.

9.    †Cui J#, Xie J#, Qin L, Chen S, Zhao Y*, Wu D*. A unique acute myeloid leukemia patient with cryptic NUP98-NSD1 gene and ASXL1 mutation. Leuk Lymphoma 2016;57:196-8.

10.   †Dong L, Wang H, Dong N, Zhang C, Xue B, Wu Q*. Localization of corin and atrial natriuretic peptide expression in human renal segments. Clin Sci (Lond) 2016;130:1655-64.

11.   †Fang Y#, Wang J#, Xu L, Cao Y, Xu F, Yan L, Nie M, Yuan N, Zhang S, Zhao R, Wang H, Wu M, Zhang X, Wang J*. Autophagy maintains ubiquitination-proteasomal degradation of Sirt3 to limit oxidative stress in K562 leukemia cells. Oncotarget 2016;7:35692-702.

12.   Han S*, Lee SJ, Kim KE, Lee HS, Oh N, Park I, Ko E, Oh SJ, Lee YS, Kim D, Lee S, Lee DH, Lee KH, Chae SY, Lee JH, Kim SJ, Kim HC, Kim S, Kim SH, Kim C, Nakaoka Y, He Y, Augustin HG, Hu J, Song PH, Kim YI, Kim P, Kim I, Koh GY*. Amelioration of sepsis by TIE2 activation-induced vascular protection. Sci Transl Med 2016;8:335ra55. 

13.   †He H, Zheng N, Song Z, Kim KH, Yao C, Zhang R, Zhang C, Huang Y, Uckun FM, Cheng J, Zhang Y, Yin L. Suppression of hepatic inflammation via systemic siRNA delivery by membrane-disruptive and endosomolytic helical polypeptide hybrid nanoparticles. ACS Nano 2016;10:1859-70. 

14.   †He J#, Du L#, Bao M, Zhang B, Qian H, Zhou Q*, Cao Z*. Oroxin A inhibits breast cancer cell growth by inducing robust endoplasmic reticulum stress and senescence. Anticancer Drugs 2016;27:204-15.

15.   †He S*, Huang S, Shen Z*. Biomarkers for the detection of necroptosis. Cell Mol Life Sci  2016;73:2177-81.

16.   †Hu Z#, Song B#, Xu L, Zhong Y, Peng F, Ji X, Zhu F, Yang C, Zhou J, Su Y, Chen S, He Y*, He S*. Aqueous synthesized quantum dots interfere with the NF-κB pathway and confer anti-tumor, anti-viral and anti-inflammatory effects. Biomaterials 2016;108:187-96.

17.   Huang J#, Zhou Y#, Su X, Lyu Y, Tao L, Shi X, Liu P, Long Z, Ruan Z, Xiao B, Xi W, Zhou Q, Mao J*, Xi X*. Roles of integrin β3 cytoplasmic tail in bidirectional signal transduction in a trans-dominant inhibition model. Front Med 2016;10:311-9.

18.   †Li Y, Song YH, Yu XY. Letter by Li et al regarding article, "MiR-125b is critical for fibroblast-to-myofibroblast transition and cardiac fibrosis". Circulation 2016;133:e713.

19.   †Li Z#, Zhang P#, Lu W, Peng L, Zhao Y*, Chen G*. Ratiometric fluorescent pH probes based on glycopolymers. Macromol Rapid Commun 2016;37:1513-9.

20.   †Lin D#, Lei L#, Liu Y, Zhang Y, Hu B, Bao G, Song Y, Jin Z, Liu C, Mei Y, Sandikin D, Wu Y, Zhao L, Yu X, Liu H*. Membrane IL1α inhibits the development of hepatocellular carcinoma via promoting T- and NK-cell activation. Cancer Res 2016;76:3179-88.

21.   Liu K#, Jian Y#, Sun X#, Yang C, Gao Z, Zhang Z, Liu X, Li Y, Xu J, Jing Y, Mitani S, He S, Yang C*. Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion. J Cell Biol 2016;212:181-98.

22.   †Liu X#, Xu D#, Wang Y, Chen T, Wang Q, Zhang J, You T*, Zhu L*. Glaucocalyxin A ameliorates myocardial ischemia-reperfusion injury in mice by suppression of microvascular thrombosis. Med Sci Monit 2016;22:3595-604.

23.   †Ma J#, Zeng F#, Ma C#, Pang H, Fang B, Lian C, Yin B, Zhang X*, Wang Z*, Xia J*. Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. Am J Cancer Res 2016;6:1384-95.

24.   Pan J, Dinh TT, Rajaraman A, Lee M, Scholz A, Czupalla CJ, Kiefel H, Zhu L, Xia L, Morser J, Jiang H, Santambrogio L, Butcher EC*. Patterns of expression of factor VIII and von Willebrand factor by endothelial cell subsets in vivo. Blood 2016;128:104-9.

25.   †Su J#, Wang L#, Yin X#, Zhao Z, Hou Y, Ye X, Zhou X*, Wang Z*. Rottlerin exhibits anti-cancer effect through inactivation of S phase kinase-associated protein 2 in pancreatic cancer cells. Am J Cancer Res 2016;6:2178-91.

26.   †Su J#, Zhou X#, Wang L#, Yin X, Wang Z*. Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells. Am J Cancer Res 2016;6:1949-62.

27.   †Tang C*, Wang Y, Lei D, Huang L, Wang G, Chi Q, Zheng Y, Gachet C, Mangin PH, Zhu L. Standardization of a well-controlled in vivo mouse model of thrombus formation induced by mechanical injury. Thromb Res 2016;141:49-57.

28.   †Tang J, Li J, Zhu X, Yu Y, Chen D, Yuan L, Gu Z, Zhang X, Qi L, Gong Z, Jiang P, Yu J, Meng H, An G, Zheng H*, Yang L*. Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells. Oncotarget 2016;7:34070-83.

29.   †Tang X#, Song YH#, Sun A, Ruan C, Wu D*. Successful treatment of relapsed acute myeloid leukemia without chemotherapy. J Clin Oncol 2016;34:e117-9.

30.   †Tao H#, Ma X#, Su G, Yin J, Xie X, Hu C, Chen Z, Tan D, Xu Z, Zheng Y, Liu H, He C, Mao ZJ, Yin H, Wang Z, Chang W, Gale RP, Chen Z, Wu D, Yin B*. BCL11A expression in acute myeloid leukemia. Leuk Res 2016;41:71-5.

31.   †Wang J, Zhao M, Xiao J, Wu M, Song Y*, Yin Y*. E-Cadherin, CD44v6, and insulin-like growth Factor-II mRNA-binding protein 3 expressions in different stages of hydatidiform moles. J Biochem Mol Toxicol 2016;30:455-61.

32.   †Wang J#, Fang Y#, Yan L, Yuan N, Zhang S, Xu L, Nie M, Zhang X, Wang J*. Erythroleukemia cells acquire an alternative mitophagy capability. Sci Rep 2016;6:24641.

33.   †Wang L, Hou Y, Yin X, Su J, Zhao Z, Ye X, Zhou X, Zhou L*, Wang Z*. Rottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cells. Oncotarget 2016;7:69770-82.

34.   †Wang X#, Zhi Q#, Liu S#, Xue S#, Shen C, Li Y, Wu C, Tang Z, Chen W, Song JL, Bao M, Song Y*, Zhou J*. Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach. Sci Rep 2016;6:38871.

35.   †Weng Z#, Yao J#, Chan RH#, He J, Yang X, Zhou Y*, He Y*. Prognostic value of late gadolinium enhancement cardiac magnetic resonance in hypertrophic cardiomyopathy: a meta-analysis. JACC Cardiovasc Imaging 2016;9:1392-402.

36.   †Wu J#, Xiao L#, Zhou H#, Liu H, Ge Y, Yang J, Li Y, Wu D, Zhao Y*, Zhang X*. ZFX modulates the growth of human leukemic cells via B4GALT1. Acta Biochim Biophys Sin (Shanghai) 2016;48:1120-7.

37.   Xie J#, Wang J#, Cheng S, Zheng L, Ji F, Yang L, Zhang Y, Ji H*. Expression of immune checkpoints in T cells of esophageal cancer patients. Oncotarget 2016;7:63669-78.

38.   †Xu Z#, Li J#, Wu Y, Sun Z, Luo L*, Hu Z, He S, Zheng J*, Zhang H, Zhang X*. Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system. Eur J Med Chem 2016;108:154-65.

39.   †Xu Z, Xu X, O'Laoi R, Ma H, Zheng J, Chen S, Luo L, Hu Z, He S, Li J, Zhang H, Zhang X*. Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold. Bioorg Med Chem 2016;24:5861-72.

40.   †Yang C, He S*. Heat shock protein 90 regulates necroptosis by modulating multiple signaling effectors. Cell Death Dis 2016;7:e2126.

41.   †Yin J#, Zhang F#, Tao H, Ma X, Su G, Xie X, Xu Z, Zheng Y, Liu H, He C, Mao ZJ, Wang Z, Chang W, Gale RP, Wu D*, Yin B*. BCL11A expression in acute phase chronic myeloid leukemia. Leuk Res 2016;47:88-92.

42.   †Yin X#, Zhang Y#, Su J#, Hou Y, Wang L, Ye X, Zhao Z, Zhou X, Li Y*, Wang Z*. Rottlerin exerts its anti-tumor activity through inhibition of Skp2 in breast cancer cells. Oncotarget 2016;7:66512-24.

43.   †You F, Jiang L, Zhang B, Lu Q, Zhou Q, Liao X, Wu H, Du K, Zhu Y, Meng H, Gong Z, Zong Y, Huang L, Lu M, Tang J, Li Y, Zhai X, Wang X, Ye S, Chen D, Yuan L, Qi L, Yang L*. Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells. Sci China Life Sci 2016;59:386-97.

44.   †You T, Wang Q, Zhu L*. Role of autophagy in megakaryocyte differentiation and platelet formation. Int J Physiol Pathophysiol Pharmacol 2016;8:28-34.

45.   †Yu X, He S*. The interplay between human herpes simplex virus infection and the apoptosis and necroptosis cell death pathways. Virol J 2016;13:77.

46.   †Zhang B, Han H, Fu S, Yang P, Gu Z, Zhou Q*, Cao Z*. Dehydroeffusol inhibits gastric cancer cell growth and tumorigenicity by selectively inducing tumor-suppressive endoplasmic reticulum stress and a moderate apoptosis. Biochem Pharmacol 2016;104:8-18.

47.   Zhang P#, Hong H#, Sun X#, Jiang H, Ma S, Zhao S, Zhang M, Wang Z*, Jiang C*, Liu H*. MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells. Am J Cancer Res 2016;6:141-56.

48.   Zhang XD, Baladandayuthapani V, Lin H, Mulligan G, Li B, Esseltine DL, Qi L, Xu J, Hunziker W, Barlogie B, Usmani SZ, Zhang Q, Crowley J, Hoering A, Shah JJ, Weber DM, Manasanch EE, Thomas SK, Li BZ, Wang HH, Zhang J, Kuiatse I, Tang JL, Wang H, He J, Yang J, Milan E, Cenci S, Ma WC, Wang ZQ, Davis RE, Yang L*, Orlowski RZ*. Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR/JAK1/STAT3 signaling. Cancer Cell 2016;29:1-14.

49.   †Zhao L#, Hu B#, Zhang Y, Song Y, Lin D, Liu Y, Mei Y, Sandikin D, Sun W, Zhuang M, Liu H*. An activation-induced IL-15 isoform is a natural antagonist for IL-15 function. Sci Rep 2016;6:25822.

50.   †Zheng N#, Huo Z#, Zhang B, Meng M, Cao Z, Wang Z*, Zhou Q*. Thrombomodulin reduces tumorigenic and metastatic potential of lung cancer cells by up-regulation of E-cadherin and down-regulation of N-cadherin expression. Biochem Biophys Res Commun 2016;476:252-9.

51.   †Zheng N, Wang Z*, Wei W*. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins. Int J Biochem Cell Biol 2016;73:99-110.

52.   †Zheng N, Wei W*, Wang Z*. Emerging roles of FGF signaling in hepatocellular carcinoma. Transl Cancer Res 2016;5:1-6.

53.   †Zheng N, Zhou Q, Wang Z*, Wei W*. Recent advances in SCF ubiquitin ligase complex: Clinical implications. Biochim Biophys Acta 2016;1866:12-22.

54.   †Zheng N#, Dai X#, Wang Z*, Wei W*. A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle. Cell Cycle 2016;15:3042-7.

55.   †Zhou J#, Liu B#, Liang C, Li Y*, Song YH*. Cytokine signaling in skeletal muscle wasting. Trends Endocrinol Metab 2016;27:335-47.

56.   †Zhou X#, Su J#, Feng S#, Wang L, Yin X, Yan J*, Wang Z*. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells. Oncotarget 2016;7:79076-88.